Biomarker Identification in Breast Cancer: Beta-Adrenergic Receptor Signaling and Pathways to Therapeutic Response

Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kafetzopoulou, Liana E., Boocock, David J., Dhondalay, Gopal Krishna R., Powe, Desmond G., Ball, Graham R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology (RNCSB) Organization 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962150/
https://www.ncbi.nlm.nih.gov/pubmed/24688711
http://dx.doi.org/10.5936/csbj.201303003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962150/
https://www.ncbi.nlm.nih.gov/pubmed/24688711
http://dx.doi.org/10.5936/csbj.201303003

Ejemplares similares